Predicting sudden cardiac death in adults with congenital heart disease

Jose M Oliver1,2, Pastora Gallego3, Ana Elvira Gonzalez2

  • 1Adult Congenital Heart Disease Unit, Department of Cardiology, Hospital General Universitario Gregorio Marañon, Instituto de Investigación Sanitaria Gregorio Marañón, Facultad de Medicina, Universidad Complutense de Madrid and CIBERCV, Madrid, Spain.

Insights

A new logistic regression model accurately predicts sudden cardiac death (SCD) and sudden cardiac arrest (SCA) in adults with congenital heart disease (ACHD). This model, using lesion-specific risk and clinical factors, improves risk stratification for primary prevention strategies.

Area of Science:

  • Cardiology
  • Medical Informatics

Background:

  • Adults with congenital heart disease (ACHD) have an increased risk of sudden cardiac death (SCD) and sudden cardiac arrest (SCA).
  • Accurate risk prediction is crucial for guiding primary prevention strategies in this population.

Purpose of the Study:

  • To develop, calibrate, test, and validate a logistic regression model for predicting SCD and SCA risk in ACHD patients.
  • To incorporate baseline lesion-specific risk stratification and individual characteristics into the predictive model.

Main Methods:

  • Combined data from a single-center cohort (3311 ACHD patients) and a multicenter case-control group (207 cases, 2287 controls).
  • Derived a risk model using logistic regression on development and validation datasets.
  • Stratified patients into four lesion-specific risk clusters based on cumulative incidence.

Main Results:

  • Identified key predictors: lesion-specific cluster, young age, male sex, syncope, ischemic heart disease, ventricular arrhythmias, QRS duration, and ventricular dysfunction.
  • The model demonstrated high accuracy in discrimination (C-index 0.91) and calibration in the validation dataset.
  • Achieved a 29% increase in sensitivity for SCD/SCA prediction compared to current guidelines, with minimal specificity change.

Conclusions:

  • A lesion-specific risk stratification combined with clinical variables significantly improves SCD/SCA risk prediction in ACHD.
  • The developed model offers a more accurate approach to identify high-risk individuals for targeted primary prevention.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
263
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
234
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
319
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
134
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
370
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
239